About

Dr. James Hagood, UCSD

 

One of Dr. Hagood’s clinical interests is Childhood Interstitial Lung Disease (ChILD), a collection of rare disorders which cause diffuse alterations in the lungs. He has worked closely with the ChILD Foundation to develop educational materials for families living with ChILD. The NIH and a number of Foundations have funded Dr. Hagood’s studies over the past 20 years on the role of fibroblasts in lung fibrosis. Although his major research focus has been idiopathic pulmonary fibrosis (IPF), a disease which affects only adults, recent data has shown that many of the molecular pathways which control the development of the lung in infancy and childhood are re-expressed in IPF and other lung diseases in adults. Dr. Hagood’s lab recently made the observation that epigenetic regulation, which has been shown to control such diverse processes as obesity and cancer, is also important in lung fibrosis. Dr. Hagood is excited about collaborating with other scientists to better understand and treat lung diseases.